Isracann Biosciences Inc.

CNSX: IPOT


Canadian symbol: IPOT.CN
US symbol: ISCNF

Currency in CAD

Valuation Measures

Market Cap (intraday) 530.19M
Enterprise Value 327.64M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.14
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-2.47

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-16.07%
S&P500 52-Week Change 314.38%
52 Week High 30.6800
52 Week Low 30.1500
50-Day Moving Average 30.2370
200-Day Moving Average 30.2968

Share Statistics

Avg Vol (3 month) 388.31k
Avg Vol (10 day) 356.3k
Shares Outstanding 5134.19M
Float 124.29M
% Held by Insiders 10.76%
% Held by Institutions 10.02%
Shares Short (Sep. 14, 2020) 441.1k
Short Ratio (Sep. 14, 2020) 40.55
Short % of Float (Sep. 14, 2020) 4N/A
Short % of Shares Outstanding (Sep. 14, 2020) 40.03%
Shares Short (prior month Aug. 13, 2020) 472.9k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:3
Last Split Date 3Oct. 16, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends May 30, 2020
Most Recent Quarter (mrq)May 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-31.42%
Return on Equity (ttm)-114.20%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -11.18M
Net Income Avi to Common (ttm)-23.92M
Diluted EPS (ttm)-0.2610
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.89M
Total Cash Per Share (mrq)0.03
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.19
Book Value Per Share (mrq)0.20

Cash Flow Statement

Operating Cash Flow (ttm)-10.4M
Levered Free Cash Flow (ttm)4.06M

mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen




Cannabis Market and Business News

Real-time cannabis business news from hundreds of sources. Never miss the news that matters the most.




Company News Date
IPOT.CN
Isracann Biosciences
2 months ago
IPOT.CN
Isracann Biosciences
2 months ago
IPOT.CN
Isracann Biosciences
3 months ago
IPOT.CN
Isracann Biosciences
5 months ago
IPOT.CN
Isracann Biosciences
5 months ago
IPOT.CN
Isracann Biosciences
7 months ago
IPOT.CN
Isracann Biosciences
7 months ago
IPOT.CN
Isracann Biosciences
10 months ago
IPOT.CN
Isracann Biosciences
10 months ago
IPOT.CN
Isracann Biosciences
10 months ago
IPOT.CN
Isracann Biosciences
10 months ago
IPOT.CN
Isracann Biosciences
10 months ago
IPOT.CN
Isracann Biosciences
10 months ago
IPOT.CN
Isracann Biosciences
10 months ago
IPOT.CN
Isracann Biosciences
11 months ago
IPOT.CN
Isracann Biosciences
11 months ago
IPOT.CN
Isracann Biosciences
11 months ago
IPOT.CN
Isracann Biosciences
11 months ago
IPOT.CN
Isracann Biosciences
11 months ago
IPOT.CN
Isracann Biosciences
11 months ago

Analysts data is not available


Insiders transactions are updated every hour.

Major Holders

Currency in CAD
Breakdown
0.76%% of Shares Held by All Insider
0.02%% of Shares Held by Institutions
0.02%% of Float Held by Institutions
2Number of Institutions Holding Shares
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by Isracann Biosciences Inc.


Isracann Welcomes International Cannabis Exports in Israel

Isracann Welcomes International Cannabis Exports in Israel

VANCOUVER, British Columbia, Oct. 14, 2020 -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer is pleased to announce that the government of Israel has officially enacted the legislation for the exp... Read More...
Isracann Updates Cannabis Farm Developments and Advises Processing Facility Expansion Underway

Isracann Updates Cannabis Farm Developments and Advises Processing Facility Expansion Underway

VANCOUVER, British Columbia, Sept. 01, 2020 -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer today provides a corporate review and update of its activities in Israel.Working closely with our Isra... Read More...
Isracann Prepares for Israel's New Cannabis Export Permit Process and Announces New COO

Isracann Prepares for Israel’s New Cannabis Export Permit Process and Announces New COO

VANCOUVER, British Columbia, June 04, 2020 -- Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer is pleased by the recent government approval permitting the export of cannabis for sale to foreign med... Read More...
Isracann Increases Focus on EU Demand

Isracann Increases Focus on EU Demand

VANCOUVER, British Columbia, May 14, 2020 -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer is accelerating efforts to service an anticipated increase in demand for both domestic and European mark... Read More...
Abacus Health Products Announces Release Date, Conference Call Details for 2019 Fourth Quarter and Year-End Financial Results

Abacus Health Products Announces Release Date, Conference Call Details for 2019 Fourth Quarter and Year-End Financial Results

Abacus Health Products, Inc. (CSE: ABCS, OTCQB: ABAHF) ("Abacus") will release its 2019 fourth quarter and year-end financial results on Wednesday, April 29,2020, prior to the market open and management will host a conference call at 10:00 AM Eastern Time to review the financial results.Conference Call & Live Audio Webcast Details:All... Read More...
Isracann Closes JV Cannabis Farm Production Agreement With 3-Year Offtake in Israel

Isracann Closes JV Cannabis Farm Production Agreement With 3-Year Offtake in Israel

VANCOUVER, British Columbia, April 08, 2020 -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is pleased to announce that further to its news release o... Read More...
Isracann Enters JV for Near-Term Cannabis Farm Production Opportunity in Israel

Isracann Enters JV for Near-Term Cannabis Farm Production Opportunity in Israel

VANCOUVER, British Columbia, March 24, 2020 -- Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is pleased to announce its entry into a joint venture ag... Read More...
Isracann Receives Project Characterization Report and Engages EU GMP Consultancy

Isracann Receives Project Characterization Report and Engages EU GMP Consultancy

VANCOUVER, British Columbia, Jan. 09, 2020 -- Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is pleased to advise it has received the results of its previously comm... Read More...
Isracann Advances New Partnership with Late Stage Cannabis Farm in Israel

Isracann Advances New Partnership with Late Stage Cannabis Farm in Israel

VANCOUVER, British Columbia, Dec. 17, 2019 -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is pleased to announce it has entered into an MOU for a joint venture wi... Read More...
Isracann Biosciences Receives Land Use & Facility Approvals from Israeli Land Authority and Amends Warrants

Isracann Biosciences Receives Land Use & Facility Approvals from Israeli Land Authority and Amends Warrants

VANCOUVER, British Columbia, Nov. 28, 2019 -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is pleased to advise that it has received the requisite facility design ... Read More...
Isracann Biosciences Advances Architectural and Security Plans for Israeli Project

Isracann Biosciences Advances Architectural and Security Plans for Israeli Project

--Company engages respected contractors with Cannabis sector experience to ensure timely acceptance by government agenciesVANCOUVER, British Columbia, Nov. 05, 2019 -- Isracann Biosciences Inc. (CSE:IPOT) formerly Atlas Blockchain Group Inc. (CSE:AKE) (XFRA:A2PT0E) (OTC:ATLED) (the “Company”) an Israel-based company focused on becoming a ... Read More...
Coming Soon.

Delayed data (1h)


Share this page